Taking The Guesswork Out Of Feasibility Assessment In Oncology Trials

By Otis Johnson, Vice President, Clinical Research and Susie Kim, Associate Director, Feasibility & Clinical Informatics, INC Research/InVentiv Health

The scientific progress being made in cancer research has never been more encouraging or more rewarding. Yet, virtually all oncology drug sponsors face an uphill battle in what one would expect to be the easiest part of the research process: recruiting patients for clinical trials. Despite the seriousness of the diagnosis—or perhaps because of it—only three percent of adult patients with cancer participate in clinical trials. As a result, under-enrollment is common.